Jindrich Kopecek, Ph.D.

Distinguished Professor
University of Utah

Poster(s):

• (T0930-04-21) Optimizing Immunotherapy of Ovarian Cancer — Nanomedicine Strategies for Heating ‘Cold’ Tumor with Concurrent PD-L1 Attenuation
  Tuesday, October 22, 2024

  9:30 AM – 10:30 AM MT

• (W1030-04-20) Combination of Multivalent DR5 Receptor Clustering Agonists and Histone Deacetylase Inhibitors for Treatment of Colon Cancer
  Wednesday, October 23, 2024

  10:30 AM – 11:30 AM MT

• (M1230-04-22) Novel Personalized Treatment for Multiple Myeloma: Multi-Antigen T Cell Hybridizers for T Cell Activation
  Monday, October 21, 2024

  12:30 PM – 1:30 PM MT

• (M1330-04-20) Immunomodulation Improves Cancer Cell Clearance During Multi-Antigen T Cell Hybridizer Therapy
  Monday, October 21, 2024

  1:30 PM – 2:30 PM MT

• (T1330-04-21) Repurposing Paclitaxel via Vector-Guided Brain Delivery for Alzheimer Disease Treatment
  Tuesday, October 22, 2024

  1:30 PM – 2:30 PM MT

• (T1430-04-23) Boosting Checkpoint Immunotherapy with 2nd Generation HPMA Polymer Conjugates with Synchronous PD-L1 Attenuation
  Tuesday, October 22, 2024

  2:30 PM – 3:30 PM MT

• (T1530-04-21) Development of a New Modality with Strong Cancer Immunotherapeutic Effect (CITE) for Multiple Myeloma Treatment
  Tuesday, October 22, 2024

  3:30 PM – 4:30 PM MT